<qa>  How many patients will be randomized to Arm1 ASA 160 mg once daily?Several studies have shown beneficial effect of ASA on primary prevention of CRC and the investigators group and others have shown a potential association of ASA also taken after the diagnosis on CRC survival in registry-based studies secondary prevention. Up to 800 patients operated for CRCLM will be randomized to Arm1 ASA 160 mg once daily or Arm2 Placebo for a period of 3 years or till disease recurrence. The patients will be treated and followed up according to standard of care and the National Guidelines. 